Cancer

M. Mongiat - Multimerin-2: a gatekeeper of vascular stability

G. Tonon - D. Lazarevic - From targeted therapies to cancer evolution: a new paradigm to tackle cancer resistance

M. Rossi - Role of protein Ubiquitylation in tumor-cell migration and invasion

S. Deaglio - Tumor-host interactions in chronic lymphocytic leukemia: moving up a NOTCH?

K. Stamatopoulos - Chronic lymphocytic leukemia: subset stories

M. Ruvo - Synthetic peptide libraries: a source of bioactive compounds

<encoded>Sandro De Falco, Institute of Genetics and Biophysics “Adriano Buzzati Traverso”, CNR, Naples, ITALY speaks on "Target-independent suppression of angiogenesis by human IgG1 antibodies and IVIg via FcyRI".This seminar has been recorded by ICGEB Trieste

Sandro De Falco, Institute of Genetics and Biophysics “Adriano Buzzati Traverso”, CNR, Naples, ITALY speaks on "Target-independent suppression of angiogenesis by human IgG1 antibodies and IVIg via FcyRI".This seminar has been recorded by ICGEB Trieste

S. De Falco - Target-independent suppression of angiogenesis by human IgG1 antibodies and IVIg via FcyRI

C. Cabal - Quantitative evaluation of complex kinetics bio process related to drug development by Magnetic Resonance. Cuban experiences

R. Dalla Favera - Genomics of B cell malignancy

V. Joukov - Elucidating the mechanisms of mitotic centrosome and spindle assembly and their deregulation in disease

B. Amati -Dissecting Myc-dependent transcriptional programs during tumor progression

F. Giancotti -Shedding Light on Merlin Wizardry

G. Blandino - Loss of Tumor Suppressor microRNA activities in human cancers

L. Zerbini - All-polymer nano- and microfluidic systems for large scale Lab-on-Chip applications

K. Wellen - Cancer Cell Metabolic Reprogramming: Links to the Epigenome

Specialized presentations on cancer - the uncontrolled growth of abnormal cells in the body.

English

hubhopper

Cancer

hubhopper